CV Therapeutics, Inc. (NASDAQ:CVTX.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on the discovery, development and commercialization of new small molecule drugs for the treatment of cardiovascular diseases.

Recs

0
Player Avatar FleaBagger (98.34) Submitted: 1/28/2009 10:43:37 AM : Underperform Start Price: $15.37 CVTX.DL Score: -29.79

Will drift down/sideways for a month or so as buyout-hopeful buyers realize it won't sell to Astrella. Buy around 13 or even 14.

Report this Post 1 Comment
Member Avatar kaskoosek (99.69) Submitted: 2/1/2009 1:01:44 AM
Recs: 0

I usually dislike large jumps in one day.Acceptable short.

Featured Broker Partners


Advertisement